Kronos Bio Performance
| KRONDelisted Stock | USD 0.88 0.00 0.00% |
The company secures a Beta (Market Risk) of -0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Kronos Bio are expected to decrease at a much lower rate. During the bear market, Kronos Bio is likely to outperform the market. Kronos Bio right now secures a risk of 0.0%. Please verify Kronos Bio maximum drawdown, as well as the relationship between the expected short fall and day median price , to decide if Kronos Bio will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Kronos Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Kronos Bio is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Kronos |
Kronos Bio Relative Risk vs. Return Landscape
If you would invest 88.00 in Kronos Bio on November 9, 2025 and sell it today you would earn a total of 0.00 from holding Kronos Bio or generate 0.0% return on investment over 90 days. Kronos Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Kronos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Kronos Bio Target Price Odds to finish over Current Price
The tendency of Kronos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.88 | 90 days | 0.88 | about 17.39 |
Based on a normal probability distribution, the odds of Kronos Bio to move above the current price in 90 days from now is about 17.39 (This Kronos Bio probability density function shows the probability of Kronos Stock to fall within a particular range of prices over 90 days) .
Kronos Bio Price Density |
| Price |
Predictive Modules for Kronos Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kronos Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kronos Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kronos Bio is not an exception. The market had few large corrections towards the Kronos Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kronos Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kronos Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | -0.4 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | -0.01 |
Kronos Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kronos Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kronos Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kronos Bio is not yet fully synchronised with the market data | |
| Kronos Bio has some characteristics of a very speculative penny stock | |
| Kronos Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.85 M. Net Loss for the year was (86.08 M) with profit before overhead, payroll, taxes, and interest of 9.19 M. | |
| Kronos Bio currently holds about 267.89 M in cash with (65.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 24.0% of the company outstanding shares are owned by corporate insiders |
Kronos Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kronos Stock often depends not only on the future outlook of the current and potential Kronos Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kronos Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 60.1 M | |
| Cash And Short Term Investments | 112.4 M |
Kronos Bio Fundamentals Growth
Kronos Stock prices reflect investors' perceptions of the future prospects and financial health of Kronos Bio, and Kronos Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kronos Stock performance.
| Return On Equity | -0.59 | |||
| Return On Asset | -0.22 | |||
| Operating Margin | (3.42) % | |||
| Current Valuation | (21.99 M) | |||
| Shares Outstanding | 60.97 M | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 5.84 X | |||
| Revenue | 9.85 M | |||
| EBITDA | (61.72 M) | |||
| Cash And Equivalents | 267.89 M | |||
| Cash Per Share | 4.72 X | |||
| Total Debt | 24.9 M | |||
| Debt To Equity | 0.11 % | |||
| Book Value Per Share | 1.31 X | |||
| Cash Flow From Operations | (65.44 M) | |||
| Earnings Per Share | (1.07) X | |||
| Total Asset | 124.36 M | |||
| Retained Earnings | (594.94 M) | |||
About Kronos Bio Performance
By examining Kronos Bio's fundamental ratios, stakeholders can obtain critical insights into Kronos Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Kronos Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company was incorporated in 2017 and is headquartered in San Mateo, California. Kronos Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.Things to note about Kronos Bio performance evaluation
Checking the ongoing alerts about Kronos Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kronos Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kronos Bio is not yet fully synchronised with the market data | |
| Kronos Bio has some characteristics of a very speculative penny stock | |
| Kronos Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.85 M. Net Loss for the year was (86.08 M) with profit before overhead, payroll, taxes, and interest of 9.19 M. | |
| Kronos Bio currently holds about 267.89 M in cash with (65.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 24.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kronos Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kronos Bio's stock is overvalued or undervalued compared to its peers.
- Examining Kronos Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kronos Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kronos Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kronos Bio's stock. These opinions can provide insight into Kronos Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Kronos Stock
If you are still planning to invest in Kronos Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kronos Bio's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |